Baron & Budd Announces $22 Million Settlement in Lawsuit Against the World’s Largest Eye Glass Lens Manufacturer
This ground-breaking case is the first settlement against an entity in this industry August 24,...READ MORE
National Mesothelioma Law Firm Presents Public Service Website For Mesothelioma Patients, Families
DALLAS (February 21, 2011) –Mesothelioma law firm Baron & Budd, P.C. recently relaunched Mesothelioma News, the firm’s website specifically dedicated to mesothelioma sufferers and their families. Mesothelioma News is a public service of Baron & Budd that seeks to provide valuable, relevant information about mesothelioma cancer treatments, physicians, veteran asbestos cancer issues and mesothelioma attorneys. The new version of Mesothelioma News features an updated look with more user-friendly navigation that highlights important resources for mesothelioma sufferers and their families.
“It was time for a change. We wanted to rethink how to better provide our visitors with information that’s useful to them,” said Steve Baron, head of Baron & Budd’s mesothelioma litigation section. “We are very pleased with the new Mesothelioma News and hope that consumers use it as a resource for mesothelioma and asbestos cancer information.”
As one of the first law firms to ever successfully litigate an asbestos case, the mesothelioma attorneys at Baron & Budd have dedicated more than 30 years to protecting the rights of mesothelioma sufferers and their families. The firm even teamed up with a group of experts and advocates to fight unfair class action “settlements” that would control the amount of money that could be paid to all present and future asbestos sufferers and won, ultimately convincing the United States Supreme Court that it was unconstitutional to limit the rights of asbestos suffers and their families from seeking individual financial compensation for their harms. Learn more about Baron & Budd at //baronandbudd.com/.
Visit the new Mesothelioma News at http://www.mesotheliomanews.com/ or call 1.866.844.1229 for more information.